NEW YORK (GenomeWeb News) - Illumina has won the first phase of a trial that involves plaintiff Applied Biosystems and defendants Illumina, Solexa, and ABI's former IP counsel Stephen Macevicz regarding ownership of intellectual property relating to ABI's SOLiD sequencing system, GenomeWeb Daily News has learned.

An Illumina spokeswoman confirmed by e-mail today that "a federal jury has determined that Illumina owns the patents that are the subject of the suit with Applied Biosystems, and that the case has now moved on to the infringement phase."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.